Phreesia upgraded to Buy at Citi on ‘clearer path to profitability’

As previously reported, Citi analyst Daniel Grosslight upgraded Phreesia to Buy from Neutral with a price target of $40, up from $28. He tells investors that he has been impressed by the company’s ability to accelerate growth this year and now sees "a clearer path to profitability."